IMAC Holdings, Inc. (BACK)
OTCMKTS
· Delayed Price · Currency is USD
0.0562
0.00 (0.00%)
Mar 6, 2026, 12:08 PM EST
IMAC Holdings Revenue
IMAC Holdings had revenue of $21.22K in the quarter ending September 30, 2025, a decrease of -62.30%. This brings the company's revenue in the last twelve months to $22.72K, down -68.46% year-over-year. In the year 2024, IMAC Holdings had annual revenue of $72.05K.
Revenue (ttm)
22.72K
Revenue Growth
-68.46%
P/S Ratio
9.59
Revenue / Employee
1.51K
Employees
15
Market Cap
218.01K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ModivCare | 2.69B |
| Banyan | 3.48M |
| First Choice Healthcare Solutions | 25.49K |
| CYIOS | 1.49M |
| Novo Integrated Sciences | 13.29M |
| Dental Patient Care America | 475.52K |
| Clearday | 7.06M |
| Syra Health | 7.50M |
IMAC Holdings News
- 6 months ago - Ignite Proteomics Announces Collaboration with Inova Health on a Biomarker Study for Late-Stage Cancers - GlobeNewsWire
- 7 months ago - IMAC Holdings Announces Research Collaboration with Vanderbilt University Medical Center to Advance Immuno-Oncology Biomarker Discovery - GlobeNewsWire
- 1 year ago - Ignite Proteomics to Present Data on MHC-II as a Predictor of Pembrolizumab Response at NCCN Annual Conference - GlobeNewsWire
- 1 year ago - Ignite Proteomics Completes Acquisition of PLA Code 0249U for Its Advanced Proteomic Breast Cancer Assay - GlobeNewsWire
- 1 year ago - Ignite Proteomics Announces Publication of Study Demonstrating Superiority of Protein Activation Analysis in Predicting Breast Cancer Therapy Response - GlobeNewsWire
- 1 year ago - IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies - GlobeNewsWire
- 1 year ago - IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q - GlobeNewsWire
- 1 year ago - IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1) - GlobeNewsWire